drugset / Trial / NCT03003390

Summary

The purpose of this phase 2a, multi-center, randomized controlled study, is to explore the efficacy of early prophylaxis against catheter-associated deep venous thrombosis (CADVT) in critically ill children.

Timeline

Start
2017-04-05
Primary completion
2019-08-16
Completion
2019-08-16

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified 0.5 mg/kg Subcutaneous
Subject Enoxaparin sodium Other / unclassified 0.75 mg/kg Subcutaneous